NEW YORK — For decades, the transition into menopause was a journey often taken in silence, marked by a "grin and bear it" attitude and a lack of diverse medical options. However, as the global population of menopausal and perimenopausal women is projected to reach 1.1 billion by 2025, a paradigm shift is occurring in the healthcare industry. Led by experts like Dr. Alyssa Dweck and companies such as Bonafide Health, a new era of women’s health is emerging—one that prioritizes clinical rigor, personalized care, and hormone-free alternatives for those seeking to maintain an active lifestyle.
Main Facts: Redefining the Menopausal Experience
Menopause is increasingly being reframed not as a medical condition to be "cured," but as a natural biological transition that requires sophisticated support. Dr. Alyssa Dweck, a board-certified gynecologist and the Chief Medical Officer at Bonafide Health, is at the forefront of this movement. The central thesis of this new era is that women should not have to choose between effective relief and their personal health preferences.
While Hormone Therapy (HT) remains a highly effective option for many, a significant portion of the population—including those with specific medical contraindications or those who prefer a natural approach—requires alternatives. Bonafide Health has positioned itself as a leader in this space by developing a suite of products, such as Thermella, Revaree Plus, and Ristela, which are supported by the same "gold standard" clinical trials typically reserved for pharmaceutical drugs.
The core of the current shift lies in three pillars:
- Validation: Acknowledging that symptoms like hot flashes, brain fog, and joint pain are significant disruptions to quality of life.
- Education: Moving beyond basic biology to help women identify the subtle "first signs" of perimenopause.
- Innovation: Utilizing naturally derived ingredients with proven mechanisms of action to provide relief without the use of exogenous hormones.
Chronology: From Taboo to the "Menopause Gold Rush"
The history of menopause management has been fraught with inconsistency. In the late 20th century, Hormone Replacement Therapy (HRT) was the standard of care until the early 2000s, when the Women’s Health Initiative (WHI) study raised concerns about the risks of estrogen and progestin. This led to a dramatic drop in HT prescriptions and a generation of women left with few evidence-based options.
2010–2020: The Silent Gap
During this decade, many women turned to over-the-counter supplements that often lacked clinical backing. The "wellness" industry boomed, but the "medical" community remained largely focused on prescriptions, leaving a gap for those seeking high-quality, non-drug interventions.
2021–Present: The Rise of Specialized Care
Companies like Bonafide Health began to bridge this gap by applying pharmaceutical-level research to naturally derived compounds. Dr. Dweck notes that the current era is defined by a rejection of the "one-size-fits-all" model. Today, menopause is a central topic in the "femtech" and longevity sectors, with a focus on keeping women active—whether on the yoga mat or the mountain trail—well into their 60s and 70s.
September 2025: The Current Landscape
As of late 2025, the conversation has moved into the mainstream. Menopause is no longer a workplace taboo, and the medical community has refined its stance on HT, noting that for many women under 60, it is both safe and beneficial for bone health. Simultaneously, the demand for hormone-free solutions has reached an all-time high, driven by a desire for autonomy and safety.
Supporting Data: The Biological and Clinical Reality
The physiological impact of menopause is driven primarily by the decline of estrogen, which affects almost every system in the female body. According to data cited by Dr. Dweck and Bonafide Health, the "hallmark" symptoms—vasomotor symptoms (VMS), such as hot flashes and night sweats—affect up to 80% of women.
Clinical Rigor in Non-Hormonal Solutions
Bonafide Health distinguishes itself by conducting randomized, double-blind, placebo-controlled trials—the "gold standard" of research—on their finished products rather than just individual ingredients.
- Thermella: Developed specifically for VMS, this product utilizes naturally derived ingredients to regulate temperature without systemic hormone disruption.
- Revaree Plus: Addresses vaginal dryness, a symptom affecting approximately 50% of postmenopausal women, by restoring moisture through a hormone-free delivery system.
- Ristela: Focuses on blood flow and sexual satisfaction, addressing the drop in libido and physical response that often accompanies the decline in testosterone and estrogen.
The Perimenopause Spectrum
Research indicates that the transition (perimenopause) can begin up to 10 years before the final menstrual period. Dr. Dweck highlights "lesser-known" symptoms that data now links to this transition:
- Integumentary changes: Skin thinning, acne, and hair loss.
- Musculoskeletal issues: Unexplained joint aches and "burning tongue" syndrome.
- Neurological disruptions: Sleep fragmentation and heightened irritability.
Official Responses: Expert Insights from Dr. Alyssa Dweck
In her capacity as CMO of Bonafide Health, Dr. Dweck emphasizes that seeking treatment is an act of "self-care" and "empowerment." During recent discussions on the state of the industry, she clarified the medical community’s evolving stance on both hormonal and non-hormonal paths.
"Menopause isn’t a disease," Dr. Dweck asserts. "It’s a natural life event that impacts us all differently. For too long, women navigating menopause have been left with one-size-fits-all options."
Regarding the safety of modern treatments, Dr. Dweck points to the latest research suggests that for women who start HT within ten years of menopause or before age 60, the benefits—particularly for bone density and cardiovascular health—often outweigh the risks. However, she remains a staunch advocate for those who cannot use hormones, such as breast cancer survivors or those with a history of blood clots.
"We have a powerhouse team of scientists committed to advancing women’s health and performance," Dweck says. "Like an athlete choosing a training plan tailored to specific goals, we start by identifying naturally derived ingredients with mechanisms of action. The result is a suite of products that empower women to take back control."
Implications: The Future of Aging and Wellness
The shift toward proactive menopause management has profound implications for society, the economy, and individual longevity.
1. Economic and Workplace Impact
As more women remain in the workforce during their 50s and 60s—often reaching the peak of their careers—the management of menopause symptoms becomes an economic imperative. Untreated symptoms lead to billions of dollars in lost productivity and healthcare costs globally. By providing effective relief, companies like Bonafide are helping to retain female leadership in the global economy.
2. The Longevity and Fitness Connection
For the "active ager," menopause relief is not just about comfort; it is about performance. Whether it is maintaining the bone density required for long-distance running or the flexibility needed for yoga, managing the physiological shifts of menopause is essential for long-term mobility. The integration of menopause care into the fitness and outdoor industries (as seen with "Outside" and "Yoga Journal") signals that women are no longer willing to "sit out" their favorite activities.
3. Psychological Well-being and Relationships
The physical symptoms of menopause often bleed into emotional health and interpersonal intimacy. By addressing issues like dryness and low libido with products like Revaree Plus and Ristela, the medical community is acknowledging that sexual health is a vital component of overall wellness at any age.
4. The Empowerment of Data
The move toward symptom tracking and personalized quizzes represents a broader trend in "democratized" healthcare. When women enter their doctor’s office with a journal of their cycle changes, sleep patterns, and skin health, they move from being passive patients to active partners in their care.
Conclusion
The work of Dr. Alyssa Dweck and Bonafide Health reflects a broader cultural movement: the "un-shaming" of menopause. By combining clinical science with a holistic understanding of a woman’s life—from her career to her workout routine to her relationships—this new era of health ensures that the menopausal transition is not an end, but a pivot into a new, empowered phase of life. As hormone-free, scientifically backed options continue to proliferate, the standard of care is finally rising to meet the needs of a billion women worldwide.
